Vitrolife AB (publ) (STO:VITR)
Sweden · Delayed Price · Currency is SEK 117.80
+2.60 (2.26%)
Nov 4, 2026, 5:29 PM CET
Vitrolife AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,440 | 3,440 | 3,609 | 3,512 | 3,234 | 1,681 | |
Revenue Growth | -1.91% | -4.68% | 2.76% | 8.60% | 92.38% | 34.96% |
Cost of Revenue | 1,400 | 1,443 | 1,470 | 1,534 | 1,454 | 635 |
Gross Profit | 2,040 | 1,997 | 2,139 | 1,978 | 1,780 | 1,046 |
Selling, General & Admin | 1,307 | 1,318 | 1,232 | 1,117 | 1,002 | 503 |
Research & Development | 126 | 118 | 117 | 127 | 143 | 114 |
Other Operating Expenses | -61 | -13 | -2 | -4 | -12 | - |
Operating Expenses | 1,372 | 1,423 | 1,347 | 1,240 | 1,133 | 617 |
Operating Income | 668 | 574 | 792 | 738 | 647 | 429 |
Interest Expense | -93 | -69 | -94 | -94 | -44 | -10 |
Interest & Investment Income | 16 | 16 | 24 | 16 | 2 | 1 |
Currency Exchange Gain (Loss) | -22 | -22 | -30 | -64 | -34 | 41 |
Other Non Operating Income (Expenses) | -12 | -12 | -14 | -5 | -16 | -1 |
EBT Excluding Unusual Items | 557 | 487 | 678 | 591 | 555 | 460 |
Merger & Restructuring Charges | -15 | -15 | - | - | - | - |
Impairment of Goodwill | - | - | - | -4,250 | - | - |
Gain (Loss) on Sale of Assets | - | - | -4 | -3 | -23 | - |
Asset Writedown | -5,357 | -5,357 | - | -50 | - | - |
Pretax Income | -4,815 | -4,885 | 674 | -3,712 | 537 | 460 |
Income Tax Expense | 144 | 127 | 160 | 139 | 143 | 116 |
Earnings From Continuing Operations | -4,959 | -5,012 | 514 | -3,851 | 394 | 344 |
Minority Interest in Earnings | 2 | - | -1 | - | - | -3 |
Net Income | -4,957 | -5,012 | 513 | -3,851 | 394 | 341 |
Net Income to Common | -4,957 | -5,012 | 513 | -3,851 | 394 | 341 |
Net Income Growth | - | - | - | - | 15.54% | 18.88% |
Shares Outstanding (Basic) | 135 | 135 | 135 | 135 | 135 | 115 |
Shares Outstanding (Diluted) | 135 | 135 | 136 | 135 | 135 | 115 |
Shares Change | -0.30% | -0.07% | 0.09% | - | 18.12% | 5.60% |
EPS (Basic) | -36.70 | -37.01 | 3.79 | -28.44 | 2.91 | 2.97 |
EPS (Diluted) | -36.70 | -37.01 | 3.78 | -28.44 | 2.91 | 2.97 |
EPS Growth | - | - | - | - | -2.18% | 12.58% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 603 | 460 | 815 | 690 | 585 | 359 |
Free Cash Flow Per Share | 4.46 | 3.40 | 6.01 | 5.10 | 4.32 | 3.13 |
Dividend Per Share | 1.100 | 1.100 | 1.100 | 1.000 | 0.850 | 0.800 |
Dividend Growth | 0% | 0% | 10.00% | 17.65% | 6.25% | 0% |
Gross Margin | 59.30% | 58.05% | 59.27% | 56.32% | 55.04% | 62.22% |
Operating Margin | 19.42% | 16.69% | 21.95% | 21.01% | 20.01% | 25.52% |
Profit Margin | -144.10% | -145.70% | 14.21% | -109.65% | 12.18% | 20.29% |
Free Cash Flow Margin | 17.53% | 13.37% | 22.58% | 19.65% | 18.09% | 21.36% |
EBITDA | 1,015 | 942 | 1,168 | 1,107 | 991 | 506 |
EBITDA Margin | 29.51% | 27.38% | 32.36% | 31.52% | 30.64% | 30.10% |
D&A For EBITDA | 347 | 368 | 376 | 369 | 344 | 77 |
EBIT | 668 | 574 | 792 | 738 | 647 | 429 |
EBIT Margin | 19.42% | 16.69% | 21.95% | 21.01% | 20.01% | 25.52% |
Effective Tax Rate | - | - | 23.74% | - | 26.63% | 25.22% |